Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Pinato

Showing results (121-130 of 238) with videos related to

Pageof 24
Sort By:
Expert Review of Gastroenterology & Hepatology|October 22, 2024
Delivering adjuvant and neoadjuvant treatments in the early stages of hepatocellular carcinomaBernardo Stefanini, Giulia F Manfredi, Antonio D'Alessio, et al.
Journal of Hepatology|February 28, 2026
Efficacy of liver transplantation after response to atezolizumab-bevacizumab downstaging of intermediate and advanced hepatocellular carcinoma (ImmunoXXL)Sherrie Bhoori, Licia Rivoltini, David J Pinato, et al.
European Radiology|July 13, 2023
Consensus report from the 10th global forum for liver magnetic resonance imaging: multidisciplinary team discussionBachir Taouli, Ahmed Ba-Ssalamah, Julius Chapiro, et al.
Journal for Immunotherapy of Cancer|October 1, 2021
Trans-arterial chemoembolization as a loco-regional inducer of immunogenic cell death in hepatocellular carcinoma: implications for immunotherapyDavid J Pinato, Sam M Murray, Alejandro Forner, et al.
Journal of Hepatology|February 25, 2021
Activation and transcriptional profile of monocytes and CD8<sup>+</sup> T cells are altered in checkpoint inhibitor-related hepatitisCathrin L C Gudd, Lewis Au, Evangelos Triantafyllou, et al.
The American Journal of Gastroenterology|February 12, 2026
Antibiotic Use Linked to Worse Outcomes in Gastrointestinal and Liver Cancer Patients on Immune Checkpoint Inhibitors: A Meta-AnalysisMohammad Saeid Rezaee-Zavareh, Hamidreza Karimi-Sari, Peyvand Parhizkar Roudsari, et al.
Journal for Immunotherapy of Cancer|July 8, 2021
Clinical outcomes of patients with corticosteroid refractory immune checkpoint inhibitor-induced enterocolitis treated with infliximabJames L Alexander, Hajir Ibraheim, Bhavisha Sheth, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2018
Influence of HIV Infection on the Natural History of Hepatocellular Carcinoma: Results From a Global Multicohort StudyDavid J Pinato, Elias Allara, Ting-Yi Chen, et al.
JAMA Oncology|November 17, 2022
Association of Machine Learning-Based Assessment of Tumor-Infiltrating Lymphocytes on Standard Histologic Images With Outcomes of Immunotherapy in Patients With NSCLCMehrdad Rakaee, Elio Adib, Biagio Ricciuti, et al.
Liver Cancer|June 18, 2026
The 2024 International Liver Transplant Society and International Liver Cancer Association Consensus Recommendations for Liver Transplantation for Liver CancerSudha Kodali, Laura Kulik, Antonio D'Alessio, et al.
Pageof 24

Showing results (121-130 of 238) with videos related to

Sort By:
Pageof 24
Expert Review of Gastroenterology & Hepatology|October 22, 2024
Delivering adjuvant and neoadjuvant treatments in the early stages of hepatocellular carcinomaBernardo Stefanini, Giulia F Manfredi, Antonio D'Alessio, et al.
Journal of Hepatology|February 28, 2026
Efficacy of liver transplantation after response to atezolizumab-bevacizumab downstaging of intermediate and advanced hepatocellular carcinoma (ImmunoXXL)Sherrie Bhoori, Licia Rivoltini, David J Pinato, et al.
European Radiology|July 13, 2023
Consensus report from the 10th global forum for liver magnetic resonance imaging: multidisciplinary team discussionBachir Taouli, Ahmed Ba-Ssalamah, Julius Chapiro, et al.
Journal for Immunotherapy of Cancer|October 1, 2021
Trans-arterial chemoembolization as a loco-regional inducer of immunogenic cell death in hepatocellular carcinoma: implications for immunotherapyDavid J Pinato, Sam M Murray, Alejandro Forner, et al.
Journal of Hepatology|February 25, 2021
Activation and transcriptional profile of monocytes and CD8<sup>+</sup> T cells are altered in checkpoint inhibitor-related hepatitisCathrin L C Gudd, Lewis Au, Evangelos Triantafyllou, et al.
The American Journal of Gastroenterology|February 12, 2026
Antibiotic Use Linked to Worse Outcomes in Gastrointestinal and Liver Cancer Patients on Immune Checkpoint Inhibitors: A Meta-AnalysisMohammad Saeid Rezaee-Zavareh, Hamidreza Karimi-Sari, Peyvand Parhizkar Roudsari, et al.
Journal for Immunotherapy of Cancer|July 8, 2021
Clinical outcomes of patients with corticosteroid refractory immune checkpoint inhibitor-induced enterocolitis treated with infliximabJames L Alexander, Hajir Ibraheim, Bhavisha Sheth, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2018
Influence of HIV Infection on the Natural History of Hepatocellular Carcinoma: Results From a Global Multicohort StudyDavid J Pinato, Elias Allara, Ting-Yi Chen, et al.
JAMA Oncology|November 17, 2022
Association of Machine Learning-Based Assessment of Tumor-Infiltrating Lymphocytes on Standard Histologic Images With Outcomes of Immunotherapy in Patients With NSCLCMehrdad Rakaee, Elio Adib, Biagio Ricciuti, et al.
Liver Cancer|June 18, 2026
The 2024 International Liver Transplant Society and International Liver Cancer Association Consensus Recommendations for Liver Transplantation for Liver CancerSudha Kodali, Laura Kulik, Antonio D'Alessio, et al.
Pageof 24